A Functional Assay for the Determination of Heparin-Induced Thrombocytopenia via Flow Cytometry

Diagnostics (Basel). 2023 Sep 21;13(18):3019. doi: 10.3390/diagnostics13183019.

Abstract

Heparin-induced thrombocytopenia (HIT) is a life-threatening complication of heparin therapy (both unfractionated heparin and low-molecular-weight heparin). In our study, we examined a group of 122 patients with suspected HIT. The samples of all patients were analyzed in the first step using an immunoassay (ID-PaGIA Heparin/PF4, Hemos1L-Acustar HIT IgG, ZYMUTEST HIA Monostrip IgG) to detect the presence of antibodies against heparin-PF4 complexes (platelet factor 4). When the immunoassay was positive, the sample was subsequently analyzed for HIT with a functional flow cytometry assay, the HITAlert kit, the purpose of which was to demonstrate the ability of the antibodies present to activate platelets. A diagnosis of HIT can be made only after a positive functional test result. In this article, we present an overview of our practical experience with the use of the new functional method of analysis, HIT, with flow cytometry. In this work, we compared the mutual sensitivity of two functional tests, SRA and the flow cytometry HITAlert kit, in patients perceived as being at risk for HIT. This work aims to delineate the principle, procedure, advantages, pitfalls, and possibilities of the application of the functional test HITAlert using flow cytometry.

Keywords: heparin-induced thrombocytopenia (HIT); heparin–PF4 complex (platelet factor 4); immunological and functional assays; serotonin release assay (SRA).

Grants and funding

This research supported: projects Vega 1/0436/21, Vega 1/0479/21, the Grant of Comenius University UK/67/2023, and the Grant of Comenius University UK/151/2023.